Live Investor Briefing – Prescient Therapeutics

Please join Reach Markets Managing Director Patrick Nelson and Prescient Therapeutics CEO Steven Yatomi-Clarke for a live investor briefing.

Event Details:

Date: Wednesday 12th August
Time: 7pm AEST
Event Topics:

• Moving the cancer conversation from “fight” to “cure” with 100% response rates as shown in a recent Johnson & Johnson trial
• PTX’s relationship with the University of Pennsylvania, the minds behind the original CAR-T breakthrough
• PTX’s goal of becoming the “Intel Inside” personalised cancer therapy, and more
• How two  of PTX’s assets have been chosen as part of a COVID-19 screen program

These are live and interactive sessions, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.